Table 2.
Character | Gender | Size | Side | Localization | Margin features | Extansion | Perineural spread | Lymph-adenopathy | Enhancement pattern | |
---|---|---|---|---|---|---|---|---|---|---|
Character(r) | 1 | -,032 | ,140 | ,084 | ,247 | ,622** | -,678** | -,502** | -,490** | -,146 |
Gender(r) | -,032 | 1 | -,283 | ,149 | -,323* | -,227 | -,059 | -,133 | ,053 | -,010 |
Size(r) | ,140 | -,283 | 1 | ,066 | ,604** | ,253 | -,322* | -,036 | -,452** | -,185 |
Side(r) | ,084 | ,149 | ,066 | 1 | -,040 | ,128 | -,153 | -,064 | -,201 | -,048 |
Localization(r) | ,247 | -,323* | ,604** | -,040 | 1 | ,354** | -,340* | -,232 | -,291* | ,095 |
Margin features(r) | ,622** | -,227 | ,253 | ,128 | ,354** | 1 | -,624** | -,471** | -,445** | -,104 |
Extansion(r) | -,678** | -,059 | -,322* | -,153 | -,340* | -,624** | 1 | ,443** | ,632** | ,000 |
Perineural spread(r) | -,502** | -,133 | -,036 | -,064 | -,232 | -,471** | ,443** | 1 | ,125 | ,238 |
Lymphadenopathy(r) | -,490** | ,053 | -,452** | -,201 | -,291* | -,445** | ,632** | ,125 | 1 | ,000 |
Enhancement pattern(r) | -,146 | -,010 | -,185 | -,048 | ,095 | -,104 | ,000 | ,238 | ,000 | 1 |
Character; malignant-benign, **Correlation Significant at p<0.01 level, *Correlation Significant at p <0.05 level, r; Pearson Correlation coefficient.